skip to Main Content

Oncgnostics reaches the funding limit on seedmatch of € 750,000 early

  • 2018

Oncg­nos­tics GmbH has reached the fund­ing limit of € 750,000 on the crowd­fund­ing plat­form seed­match 39 days before the end of the cam­paign. The first fund­ing thresh­old of € 100,000 was already reported 2.5 hours after the start of the seed­match cam­paign on 14 Decem­ber 2017.

The com­pany is a spin-off of the Gyne­co­log­i­cal Clinic of the Uni­ver­sity of Jena and devel­ops — based on patented epi­ge­netic mark­ers — highly reli­able mol­e­c­u­lar biol­ogy tests for early diag­no­sis, treat­ment deci­sion and fol­low-up in can­cer diagnostics.

With the raised crowd invest­ment, oncg­nos­tics will pro­mote the posi­tion­ing and mar­ket­ing of the prod­uct Gyn­Tect® in the Euro­pean and North Amer­i­can mar­kets. Addi­tion­ally fur­ther stud­ies will be per­formed to reach a broad accep­tance of Gyn­Tect® with the health insur­ance companies.

Back To Top
×Close search